Irinotecan-d10 Hydrochloride (Major)
CAS: 718612-62-5
Ref. 3D-TDB61262
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
Irinotecan is a chemotherapeutic drug used in the treatment of colon, lung and breast cancers. It is an anti-cancer drug that blocks the synthesis of DNA by inhibiting the enzyme topoisomerase I. Irinotecan-d10 hydrochloride (major) is a water soluble form of irinotecan which has been radiolabeled with the radioactive isotope d10. This form of irinotecan has been shown to be more toxic than other forms because it does not require activation by carboxylesterases in the liver, allowing for direct delivery to tumor tissue. Irinotecan-d10 hydrochloride (major) can be used to visualise cancer cells with bioluminescence imaging and can also be used to determine if tumor cells are sensitive or resistant to chemotherapy by measuring changes in expression of factor receptors.
Propiedades químicas
Consulta técnica sobre: 3D-TDB61262 Irinotecan-d10 Hydrochloride (Major)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
